Pancreatic ductal adenocarcinoma (PDAC)PDACPACMA31
…Background Pancreatic ductal adenocarcinoma (PDAC) is characterised by a dismal prognosis and insensitivity to imm…
43articles mentioning diseases
43disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: pancreatic ductal adenocarcinoma (PDAC) ×
pancreatic ductal adenocarcinoma (PDAC)
This disease is selected. Its supporting articles are shown below.
Articles mentioning pancreatic ductal adenocarcinoma (PDAC)
43 articles · page 2 of 4pancreatic ductal adenocarcinoma (PDAC)PDAC
…jective To broadly characterise non-coding driver mutations for pancreatic ductal adenocarcinoma (PDAC).Design Using mutation calls from whole-genome sequence data in …
pancreatic ductal adenocarcinoma (PDAC)Liver metastasisKPT 9274
… Liver metastasis is a common and fatal event for patients with pancreatic ductal adenocarcinoma (PDAC). Dysregulated mitochondrial dynamics reshape biological process…
pancreatic ductal adenocarcinoma (PDAC)mucinous cystic neoplasmscystic neoplasmsintraductal papillary mucinous neoplasms (IPMNs)
…Early detection and interception of pancreatic ductal adenocarcinoma (PDAC) remain the only realistic strategies to reduce mortality and me…
93.4%
pancreatic ductal adenocarcinoma (PDAC)PDACNSUN6
…ase 6 (NSUN6), an m 5C methyltransferase, in shaping the TME of pancreatic ductal adenocarcinoma (PDAC).Design The clinical significance of NSUN6 was assessed in human…
Pancreatic ductal adenocarcinoma (PDAC)3p-RNACAR-T cell therapychimeric antigen receptor (CAR)-T cell therapy
…Background Pancreatic ductal adenocarcinoma (PDAC) remains largely refractory to chimeric antigen receptor (CAR)-T…
Pancreatic ductal adenocarcinoma (PDAC)pembrolizumab5-fluorouracilleucovorinadagrasibzenocutuzumabliposomal irinotecanNAPOLI-1 trialdaraxonrasibconventional chemotherapy
…Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest solid tumours, with 5-year surviva…
Pancreatic ductal adenocarcinoma (PDAC)CD40 agonist antibodiesOX40 ligandFLT3 ligandimmunotherapiesinterleukin-12 (IL-12)IL-1β
…Background Pancreatic ductal adenocarcinoma (PDAC) is characterized by a profoundly immunosuppressive tumor microe…
Pancreatic ductal adenocarcinoma (PDAC)amph-FITCamph-FITC vaccine
…Background Pancreatic ductal adenocarcinoma (PDAC) is one of the most difficult-to-treat cancers. This therapeutic…
pancreatic ductal adenocarcinoma (PDAC)PDACgemcitabineC-E-GKPPC
…Background The tumor microenvironment (TME) of pancreatic ductal adenocarcinoma (PDAC) is heavily infiltrated by inflammatory monocytes (IMs) and tumo…
Pancreatic ductal adenocarcinoma (PDAC)PDACSinai Health
…Background Pancreatic ductal adenocarcinoma (PDAC) is a malignant neoplasm of the pancreas characterized by late-s…
96.5%
pancreatic ductal adenocarcinoma (PDAC)immunotherapyJ Clin Oncol
…Background The tumor microenvironment (TME) of pancreatic ductal adenocarcinoma (PDAC) is characterized by limited infiltration of tumor-specific effe…